Shinji Matsumoto
9PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 06, 2026
Development of ARL4C antisense oligonucleotide with reduced off-target effects and enhanced efficacy as an anti-cancer drug.Kanae Kawai, Shinji Matsumoto, Akikazu Harada
|Apr 17, 2025
Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression.Akikazu Harada, Yoshiaki Yasumizu, Takeshi Harada
|Aug 09, 2024
Newly developed humanized anti-CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1-CKAP4 signaling.Ryota Sada, Hideki Yamamoto, Shinji Matsumoto
|Feb 21, 2024
Wnt/β-catenin signaling pathway in liver biology and tumorigenesis.Shinji Matsumoto, Akira Kikuchi
|Sep 01, 2023
GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation.Koei Shinzawa, Shinji Matsumoto, Ryota Sada
|Jun 22, 2023
Wnt Signaling Stimulates Cooperation between GREB1 and HNF4α to Promote Proliferation in Hepatocellular Carcinoma.Shinji Matsumoto, Akikazu Harada, Minami Seta
Pageof 2
Frequent Collaborators
5 joint publications
Akira Kikuchi
4 joint publications
Akikazu Harada
3 joint publications
Ryota Sada
2 joint publications
Koei Shinzawa
1 joint publications
Taku Yamamichi
1 joint publications
Takahiro Kodama
1 joint publications
Satoshi Obika
1 joint publications
Yoshiaki Yasumizu
1 joint publications
Minami Seta
1 joint publications
Masayuki Akita
